Calcium entry blockers and cardiovacular failure

Area of Science:

• Cardiovascular Pharmacology
• Ischemia Research

Background:

• Ischemia, affecting heart and other tissues, presents complex challenges in treatment.
• Calcium entry blockers (CEBs) are recognized for their beneficial effects in managing ischemic conditions.

Purpose of the Study:

• To elucidate the multifaceted mechanisms through which calcium entry blockers exert beneficial effects in treating ischemia.
• To detail the specific actions of CEBs on various cardiovascular components and cellular processes.

Main Methods:

• Review and synthesis of known pharmacological effects of calcium entry blockers.
• Analysis of their impact on vascular smooth muscle, myocardial cells, heart rate, and blood flow.
• Examination of effects on platelet aggregation, red blood cell deformability, and endothelial function.

Main Results:

• CEBs exhibit diverse actions including vasodilation, negative inotropic and chronotropic effects, and inhibition of vasospasm.
• They also reduce myogenic activity, inhibit platelet aggregation, and may improve red blood cell deformability.
• Protection of endothelial integrity and cellular protection from anoxia and calcium overload during reperfusion are key benefits.

Conclusions:

• The beneficial effects of calcium entry blockers in ischemia stem from a combination of direct cellular actions and systemic cardiovascular effects.
• In angina pectoris, CEBs improve myocardial oxygen supply-demand balance, enhance coronary perfusion, and support collateral circulation.
• Available calcium entry blockers differ in their specific potencies across various cardiovascular targets.